Emotional eaters are less likely to see results from weight loss drugs such as Ozempic compared to those motivated by sight and smell, new research suggests.

A study of type two diabetes patients carried out by Japanese scientists sought to identify the role relationship to food has on the success of GLP-1 weight loss drugs like Ozempic.

Researchers studied the diet, eating behaviour, blood sugar and weight loss of 92 diabetes patients taking GLP-1 medication over 12 months, in a bid to find out why some people responded better than others.

It found those who overeat to manage their emotions did not respond as well to weight loss drugs as those who eat too much “in response to seeing and smelling tasty food”.

The latter group “experienced more significant weight loss than individuals w

See Full Page